Kazuhisa Tsuchida

Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195

Kazuhisa Tsuchida, Zenji Makita, Sho‐ichi Yamagishi et al. · Diabetologia · 1999 · 214 citations · Full text

Medicine, Biochemistry, Pharmacology +17

Increased Levels of Vascular Endothelial Growth Factor and Advanced Glycation End Products in Aqueous Humor of Patients With Diabetic Retinopathy

M Endo, Ken Yanagisawa, Kazuhisa Tsuchida et al. · Hormone and Metabolic Research · 2001 · 64 citations

Medicine, Biochemistry, Ophthalmology +15

Switching to Once-Daily Insulin Degludec/Insulin Aspart from Basal Insulin Improves Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial

Kyu Yong Cho, Akinobu Nakamura, Chiho Oba‐Yamamoto et al. · Diabetes & Metabolism Journal · 2019 · 20 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +16

Case of fulminant type 1 diabetes induced by the anti‐programmed death‐ligand 1 antibody, avelumab

Yui Shibayama, Hiraku Kameda, Shoichiro Ota et al. · Journal of Diabetes Investigation · 2019 · 17 citations · Full text

Life Sciences, Immunology, Oncology +17

Favourable effect of the sodium‐glucose co‐transporter‐2 inhibitor canagliflozin plus the dipeptidyl peptidase‐4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open‐label, prospective, randomized, parallel‐group comparison trial (the CALMER study)

Kyu Yong Cho, Hiroshi Nomoto, Akinobu Nakamura et al. · Diabetes Obesity and Metabolism · 2019 · 13 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17